| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8531467 | International Immunopharmacology | 2018 | 8 Pages |
Abstract
Our data suggest that the use of a combination of low-dose SKA Progesterone and IL-10 may represent an opportunity for the development of new therapies in the clinical management of endometriosis.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Francesca Mancini, Domenico Milardi, Piero Carfagna, Giuseppe Grande, Vincenzo Miranda, Alessandra De Cicco Nardone, Domenico Ricciardi, Alfredo Pontecorvi, Riccardo Marana, Fiorenzo De Cicco Nardone,